Retrospective evaluation of the impact of copayment increases for specialty medications on adherence and persistence in an integrated health maintenance organization system

Clinical Therapeutics

Volumn 33, Issue 5, 2011, Pages 598-607

  Kim, Yoona A ^a,b,c   Rascati, Karen L ^a   Prasla, Karim ^b   Godley, Paul ^b   Goel, Nishi ^b   Dunlop, Desiree ^c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Adherence; Cox regression analysis; Individual growth model; Persistence; Specialty drugs

Indexed keywords

ADALIMUMAB; ANASTROZOLE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BETA1A INTERFERON; CAPECITABINE; CYCLOSPORIN; ERLOTINIB; ETANERCEPT; EXEMESTANE; GLATIRAMER; IMATINIB; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERFERON BETA SERINE; LAPATINIB; LETROZOLE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SUNITINIB; THALIDOMIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG WITHDRAWAL; FEMALE; HEALTH CARE INDUSTRY; HEALTH INSURANCE; HUMAN; INTEGRATED HEALTH MAINTENANCE ORGANIZATION SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; PATIENT COMPLIANCE; RETROSPECTIVE STUDY;

DEDUCTIBLES AND COINSURANCE; DRUG THERAPY; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; LONGITUDINAL STUDIES; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES;

EID: 79958754239     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.04.021     Document Type: Article

References (16)

1. Stern D., Reissman D. Specialty pharmacy cost management strategies of private health care payers. J Manag Care Pharm 2006, 12:736-744.
2. Sullivan S.D. The promise of specialty pharmaceuticals: are they worth the price?. J Manag Care Pharm 2008, 14:S3-S6.
3. Express Scripts 2009 Drug Trend Report. Solving for America's $163 Billion in Pharmacy-Related Waste. Published April 2010, Accessed April 30, 2010. http://www.express-scripts.com/research/studies/drugtrendreport/2009/dtrFinal.pdf.
4. Medco Health. Drug Trend Report 2009 Accessed April 30, 2010. http://filecache.drivetheweb.com/mr4enh_medco/177/2009+DRUG+TREND+REPORT.pdf.
5. Goldman D.P., Joyce G.F., Lawless G., et al. Benefit design and specialty drug use. Health Aff 2006, 25:1319-1331.
6. Stern D. Benefit design innovations to manage specialty pharmaceuticals. J Manag Care Pharm 2008, 14:S12-S16.
7. Mullins C.D., Lavallee D.C., Pradel F.G., et al. Health plans' strategies for managing outpatient specialty pharmaceuticals. Health Affairs 2006, 25:1332-1339.
8. Klepser D.G., Huether J.R., Handke L.J., Williams C.E. Effect on drug utilization and expenditures of a cost-share change from co-payment to coinsurance. J Manag Care Pharm 2007, 13:765-777.
9. Goldman D.P., Joyce G.F., Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007, 298:61-69.
10. Gleason P.P., Gunderson B.W., Gericke K.R. Are incentive-based formularies inversely associated with drug utilization in managed care?. Ann Pharmacother 2005, 39:339-345.
11. Ozminkowski R.J., Marder W.D., Hawkins K., et al. The use of disease-modifying new drugs for multiple sclerosis treatment in private-sector health plans. Clin Ther 2004, 26:1341-1354. Aug.
12. Singer J.D. Using SAS PROC MIXED to fit multilevel models, hierarchical models, and individual growth models. J Educ Behav Stat 1998, 23:323-355.
13. O'Connell A.A., McCoach D.B. Applications of hierarchical linear models for evaluations of health interventions: demystifying the methods and interpretations of multilevel models. Eval Health Prof 2004, 27:119-151.
14. Nevins T.E., Kruse L., Skeans M.A., Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001, 60:1565-1570.
15. De Geest S., Abraham I., Moons P., et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant 1998, 17:854-863.
16. Cohen J. Statistical Power for the Behavioral Sciences 1988, Hillsdale, NJ, Erlbaum. 2nd ed.